The THC gummy market isn’t broken because the chemistry is hard or bad, or because the ingredients are hard to find. It’s broken because most THC gummies are designed around selling the maximum number of units, not producing predictable, reliable experiences.
Instead, today’s THC Gummies are optimized for bright packaging, big milligram numbers, low manufacturing costs, and broad appeal—while quietly ignoring the one thing users actually care about: safe, predictable, repeatable effects.
If the same gummy can feel fine one time and overwhelming at another, and no one tells you how much you should take, it’s not user error when it goes badly. That’s a structural failure hiding behind sugar, flavoring, and dosage labels that imply precision without delivering it.

Gummies Solved the Wrong Problem
THC gummies exist because smoking is harmful and inconvenient, and tinctures feel medical and no fun. Gummies promised discretion, portability, and familiarity. They look like candy and consumers are comfortable consuming candy.
But the candy analogy breaks down when you introduce a psychoactive compound with a narrow comfort zone and a highly variable response curve. THC gummies are not candy.
The mass market treated THC like a flavoring problem—just mask the taste with artificial sweeteners and corn syrup, standardize the shape, print large numbers of milligrams on the bag, and ship it.
What it ignored was that THC is not forgiving.
The difference between a “pleasant” and “unpleasant” experience is often small, personal, hard to see, and context-dependent. The vast majority of today’s THC gummies weren’t designed to handle that.
They were designed like candy to be scaled at low cost and high margin. Like an impulse purchase at the check-out counter.
It’s an environment that rewards loud packaging and large numbers of milligrams, and no one cares all that much whether anyone buys the same product twice, so few do.

Milligrams Became a Marketing Weapon
Once gummies entered retail, milligrams turned into the dominant signal of value.
- 10mg.
- 25mg.
- 50mg.
- 500mg.
- 5,000mg.
- “Extra Strength.”
The numbers got bigger because bigger numbers sell better. Consumers were trained—explicitly or implicitly—that more milligrams meant more strength, effectiveness and more for the money… maybe even more legitimacy.

But THC doesn’t work that way…
Higher doses don’t reliably produce better experiences. In fact, in many cases, they produce worse ones. Anxiety, cognitive impairment, dissociation, time distortion—these aren’t fringe cases. They’re common outcomes of taking too much.
The industry knows this. And yet it continues to push potency because potency is easy to communicate and sells at higher points, even if consumers aren’t getting more value.
You might say that doing it right is harder to sell than doing it louder.
Consistency Is Treated as Optional
In most consumer product categories, consistency is the price of admission. If your coffee tastes different every day, you switch brands. If your medication only works sometimes, you stop trusting it. When someone pulls out a Marlboro and lights it, he or she expects it to be exactly like the last. No exceptions.
In THC gummies, inconsistent effects have been normalized.
Consumers now quietly accept that THC gummy effects can vary dramatically:
- One batch hits harder or feels stronger than another.
- One day it feels fine, the next it feels off.
- The same dose behaves differently depending on food, mood, or timing.
Instead of fixing this, the market externalized the problem. Seeing no alternative, users were simply told to “start low,” “wait longer,” and “find your sweet spot.” “If you’re not feeling it in an hour, take more.”
In other words… figure it out for yourself.
It’s a trial-and-error sort of thing. The only problem is that every time you get it wrong you feel like you might die for five hours and maybe into the next day. Oh, well… why not try again?
That’s the opposite of consumer empowerment. That’s the total abdication of responsibility. It’s also absolutely terrible advice that contributes to people taking too much.

Edibles Are a Complicated Format for Precision
It might look like making candy, but it’s not. The edible format amplifies every weakness in how THC gummies work. Delayed onset means feedback is slow. By the time someone realizes they took too much, the decision is irreversible.
Long duration of effects turn small mistakes into multi-hour commitments. One’s individual digestion introduces variability for which no label can account. Gummies stack uncertainty on top of uncertainty.
And instead of finding ways to compensate for this, most products make it worse—by compressing huge doses into small, candy-like units that encourage casual consumption.
It’s a format invites misuse, then blames the user for it. Hey, next time take less. And, thank you, Mr. Gummy Expert.

Microdosing Emerged as a Workaround
The rise of microdosing wasn’t driven by wellness influencers or Silicon Valley biohackers. It was driven by real life experience with gummies in today’s dysfunctional market.
People learned—and almost always the hard way—that gummy effects are unreliable. So, they adapted. They took less. They took small bites of their gummies. And soon, that would come to be referred to as microdosing.
Microdosing became popular because it reduced downside risk. It would be better if you knew how much you should take, but if you don’t know, best to only take a small amount. That’s most of the “science” behind microdosing.
That’s a damning indictment of the product category, but when a market’s best advice is “take less than what we sell you,” something is wrong.

The Illusion of Control
THC gummies are marketed as controlled, measured, and precise. Clean lines. Exact milligrams. Lab-tested confidence.
But, that control is too often an illusion.
A 5mg gummy doesn’t represent a standardized experience. It represents a theoretical input into a system that behaves unpredictably. The body isn’t a calculator, and the endocannabinoid system isn’t linear.
So, consumers are left with a strange mismatch: products that look scientific, producing results that feel close to random.
That gap erodes trust and engenders fear.
Why This Keeps Happening
The THC gummy market is broken because incentives are misaligned. Manufacturers could do things better, but distributors won’t pay for it. And, absent any real distinction, retailers want things cheap, as well. Consumers are getting the short end of this stick.
Retail rewards shelf appeal, not education that leads to outcome quality. Regulations encourage simple labeling, not experiential accuracy. Consumers are price-sensitive and potency-driven, especially early on, so brands compete on visibility and volume.
No one is rewarded for building gummies that are boringly consistent. Consistency doesn’t photograph well. It doesn’t fuel spikes in sales. It doesn’t differentiate quickly. So, the market keeps producing products at the lowest possible cost, that look better than they perform. It’s the definition of broken.

What Consumers Actually Want
Most people don’t want to get “as high as possible.” Rather, they want:
- Predictability
- Control
- Confidence that they’re evening won’t go sideways.
They want a product that behaves the same way it did last time. They want to know exactly what’s inside, how much to take and what they’re signing up for.
Right now, there are precious few gummies that deliver those sorts of reliable outcomes. Not none, but precious few.
So, consumers hedge. They underdose. They avoid experimenting. They treat THC gummies cautiously, even when they like the idea of them.
That caution isn’t prudishness. It’s learned behavior.

What Fixing the Market Would Require
Fixing the THC gummy market wouldn’t require breakthroughs in chemistry. It would require a shift in priorities, combined with thoughtful attention by our legislators.
It would mean:
- Designing for consistency over potency.
- Treating variability as a defect, not a given.
- Aligning dose units with human tolerance, not marketing narratives.
- Being honest about uncertainty instead of hiding it behind milligrams.
In other words, it would mean designing gummies for grown-up humans first… and for store shelves and websites, second.

The Bottom Line
Most THC gummies don’t suck because THC is bad. They suck because the market is optimized for the wrong outcomes–sales velocity, not experiential reliability. For milligrams, not potential margins of error. For novelty, not trust.
Consumers have figured this out on their own. That’s why microdosing exists. That’s why people are cautious. That’s why the category feels far more fragile than it should.
The THC gummy market isn’t broken because it wants to be, or has to be. It’s broken because its been pushed in the wrong direction by multiple forces with competing demands.
The good news is that consumer demand for THC and THC-based gummies is enormous and growing every day. It’s not easy, but the benefits clearly are driving people to find something that works for them, even if it’s a sub-optimal solution that involves some risk.
With that in mind, it’s not hard to imagine that the industry will ultimately respond to consumer demands, thus making the successful future of the THC gummy market seem all but assured.
FAQ Section
Why do THC gummies feel stronger some days than others?
THC gummy effects can vary due to tolerance, metabolism, delayed digestion, body chemistry, comfort level, and more. And, even when the milligrams are the same, outcomes can be different.
Are higher-mg THC gummies better or more effective?
No, not necessarily. Higher milligram THC gummies do not reliably produce better experiences. In many cases, higher doses increase the likelihood of anxiety, discomfort, or cognitive impairment rather than improving effects.
Why do people microdose THC gummies?
Microdosing THC emerged as a way to reduce the risk of taking too much. Because THC gummy dosage can be unpredictable, many consumers choose smaller doses to maintain control and avoid unpleasant side effects.
How long does it take for THC gummies to kick in?
THC gummies are ingested, as opposed to being inhaled, and as a result, the effects take longer to appear. While inhaling is instantaneous, ingesting takes between 30 and 60 minutes… in some cases, even a bit longer. This can lead to people taking additional doses too soon, increasing the risk of taking too much.
# # #

Martin Andelman is the co-founder and CEO at Deltrium, a company dedicated to producing the most advanced and highest quality, all-natural THC-based gummies for targeted effects available anywhere. Martin, at 64 years old, has a lifetime of familiarity with cannabis, but his intensive study of the subject over the last five years has made him a thought leader and expert.
Today, Deltrium’s products are offered in pharmacies and other alternative health providers, in addition to dispensaries and other specialty retailers.
Harnessing the power of what scientists are calling “the entourage effect,” Deltrium gummies blend THC with adaptogens and amino acids, like Cordyceps, Lion’s Mane, Ashwagandah, Passion Flower and L-Theanine, which is found in green tea.
To address the dosing problem, Deltrium’s one-of-a-kind weighted dosing algorithm, consists of questions that you answer about you in order to receive your prescribed, optimal initial dose. Our dosing algorithm took two years to develop and has been proven effective in making sure that no one take too much or too little… rather, our customers take the right amount for them.
Deltrium also includes its unique, patent-pending gummy cutter, called the DeltriumDivider, which makes it very easy to cut gummies into quarters for accurate dosing. And, Deltrium gummies are all double-blind lab tested so you always know exactly what’s inside.

